Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
Expands Sobi’s pipeline with a highly differentiated new Phase 3 asset in Gout Acquisition expected to be highly accretive to Sobi’s mid- to long-term... Read more.
Tapping into “Urban Oilfield”: Unlocking the Value of Waste Plastic Film
How can discarded plastic film be converted into fuel and turned from waste into treasure? HANGZHOU, China, Dec. 13, 2025 /PRNewswire/ — Hundreds of millions... Read more.
Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform
INCLINE VILLAGE, Nev., Dec. 13, 2025 /PRNewswire/ — Phinge would like to congratulate its Founder and CEO Robert DeMaio for being ranked #1 globally by Crunchbase.... Read more.
Official streaming platform for the Games of the Future Abu Dhabi 2025 powered by ADNOC launches ahead of opening competition
Global fans to experience the Games of the Future like never before as MOBA PC.Dota 2 competition kickoffs in Abu Dhabi DUBAI, UAE, Dec. 13, 2025 /PRNewswire/... Read more.
SmallRig and FamilyLens Launch Global Family Filmmaking Initiative at 3rd FamilyLens International Film Festival
The Initiative Aims to Address the Pain Points of Family Filmmaking BEIJING, Dec. 13, 2025 /PRNewswire/ — On December 6th, the 3rd FamilyLens International... Read more.
Rokid Breaks Crowdfunding Record in Taiwan; Official Taiwan Launch of Rokid Glasses
TAIPEI, Dec. 13, 2025 /PRNewswire/ — Rokid, a global pioneer in human-computer interaction and augmented reality, achieved a major milestone on Taiwan’s... Read more.
HiTHIUM Launches Three Breakthrough Innovations at Its Third Eco-Day, Unlocking an Intelligent Future with Long-Duration Energy Storage
XIAMEN, China, Dec. 12, 2025 /PRNewswire/ — As Long-duration Energy Storage (LDES) becomes central to overcoming renewable intermittency and enabling all-weather... Read more.
U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*
Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination... Read more.
REVERE TACTICAL OPPORTUNITIES REIT, LLC AND REVERE TACTICAL OPPORTUNITIES FUND IV, LP TO AUCTION 100% OF THE CLASS B LIMITED PARTNER INTEREST IN CASORO AVIATOR INVESTORS, LP VIA PUBLIC SALE
DALLAS, Dec. 12, 2025 /PRNewswire/ — Pursuant to Section 9-610 of the Uniform Commercial Code, Revere Tactical Opportunities REIT, LLC and Revere Tactical... Read more.
AI Infrastructure Company EverMind Released EverMemOS, Responding to Profound Challenges in AI
SAN MATEO, Calif., Dec. 12, 2025 /PRNewswire/ — AI infrastructure company EverMind has recently released EverMemOS, an open-source Memory Operating System... Read more.